The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shamrock Pharmachemi Pvt Ltd & PACs
Awaiting price reaction for this filing.
Shamrock Pharmachemi Private Limited, part of the promoter group, bought 2,68,000 equity shares (4.94%) of Shamrock Industrial Company Ltd on 28 March 2025 through an off-market transaction. The acquirer's standalone holding rose from 4.68% to 9.62% post-acquisition. Including all Persons Acting in Concert (PACs — Khokhani family members and related group entities), the combined promoter group holding increased from 38.04% to 42.98% of the company's equity. The company has 54,28,414 equity shares of Rs. 10 each as its total share capital. The deal was disclosed under SEBI SAST Regulation 29(2) and PIT Regulation 7(2) on 29 March 2025.
Positive signal for retail investors as the promoter group is increasing its stake, indicating confidence in the company. The combined promoter holding at 42.98% is now approaching the 45% open offer trigger threshold — any further acquisition by the promoter group could attract mandatory open offer obligations under SEBI takeover rules.